386 related articles for article (PubMed ID: 16007073)
21. NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells.
Qi W; Shakalya K; Stejskal A; Goldman A; Beeck S; Cooke L; Mahadevan D
Oncogene; 2008 Jul; 27(30):4210-20. PubMed ID: 18345031
[TBL] [Abstract][Full Text] [Related]
22. Up-regulation of translation eukaryotic initiation factor 4E in nucleophosmin 1 haploinsufficient cells results in changes in CCAAT enhancer-binding protein α activity: implications in myelodysplastic syndrome and acute myeloid leukemia.
Khanna-Gupta A; Abayasekara N; Levine M; Sun H; Virgilio M; Nia N; Halene S; Sportoletti P; Jeong JY; Pandolfi PP; Berliner N
J Biol Chem; 2012 Sep; 287(39):32728-37. PubMed ID: 22851180
[TBL] [Abstract][Full Text] [Related]
23. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant.
Colombo E; Martinelli P; Zamponi R; Shing DC; Bonetti P; Luzi L; Volorio S; Bernard L; Pruneri G; Alcalay M; Pelicci PG
Cancer Res; 2006 Mar; 66(6):3044-50. PubMed ID: 16540653
[TBL] [Abstract][Full Text] [Related]
24. Thr199 phosphorylation targets nucleophosmin to nuclear speckles and represses pre-mRNA processing.
Tarapore P; Shinmura K; Suzuki H; Tokuyama Y; Kim SH; Mayeda A; Fukasawa K
FEBS Lett; 2006 Jan; 580(2):399-409. PubMed ID: 16376875
[TBL] [Abstract][Full Text] [Related]
25. Absence of nucleophosmin 1 (NPM1) gene mutations in common solid cancers.
Jeong EG; Lee SH; Yoo NJ; Lee SH
APMIS; 2007 Apr; 115(4):341-6. PubMed ID: 17504301
[TBL] [Abstract][Full Text] [Related]
26. Mutations of NPM1 gene in de novo acute myeloid leukaemia: determination of incidence, distribution pattern and identification of two novel mutations in Indian population.
Ahmad F; Mandava S; Das BR
Hematol Oncol; 2009 Jun; 27(2):90-7. PubMed ID: 19365794
[TBL] [Abstract][Full Text] [Related]
27. Dissecting p53 tumor suppressor function in vivo through the analysis of genetically modified mice.
Johnson TM; Attardi LD
Cell Death Differ; 2006 Jun; 13(6):902-8. PubMed ID: 16557272
[No Abstract] [Full Text] [Related]
28. Nucleophosmin: from structure and function to disease development.
Box JK; Paquet N; Adams MN; Boucher D; Bolderson E; O'Byrne KJ; Richard DJ
BMC Mol Biol; 2016 Aug; 17(1):19. PubMed ID: 27553022
[TBL] [Abstract][Full Text] [Related]
29. Determining the contribution of NPM1 heterozygosity to NPM-ALK-induced lymphomagenesis.
Mduff FK; Hook CE; Tooze RM; Huntly BJ; Pandolfi PP; Turner SD
Lab Invest; 2011 Sep; 91(9):1298-303. PubMed ID: 21709672
[TBL] [Abstract][Full Text] [Related]
30. Nucleophosmin and human cancer.
Lim MJ; Wang XW
Cancer Detect Prev; 2006; 30(6):481-90. PubMed ID: 17113241
[TBL] [Abstract][Full Text] [Related]
31. RNA aptamers interfering with nucleophosmin oligomerization induce apoptosis of cancer cells.
Jian Y; Gao Z; Sun J; Shen Q; Feng F; Jing Y; Yang C
Oncogene; 2009 Nov; 28(47):4201-11. PubMed ID: 19734942
[TBL] [Abstract][Full Text] [Related]
32. The structure and functions of NPM1/Nucleophsmin/B23, a multifunctional nucleolar acidic protein.
Okuwaki M
J Biochem; 2008 Apr; 143(4):441-8. PubMed ID: 18024471
[TBL] [Abstract][Full Text] [Related]
33. Deletion of Peg10, an imprinted gene acquired from a retrotransposon, causes early embryonic lethality.
Ono R; Nakamura K; Inoue K; Naruse M; Usami T; Wakisaka-Saito N; Hino T; Suzuki-Migishima R; Ogonuki N; Miki H; Kohda T; Ogura A; Yokoyama M; Kaneko-Ishino T; Ishino F
Nat Genet; 2006 Jan; 38(1):101-6. PubMed ID: 16341224
[TBL] [Abstract][Full Text] [Related]
34. Nucleophosmin may act as an alarmin: implications for severe sepsis.
Nawa Y; Kawahara K; Tancharoen S; Meng X; Sameshima H; Ito T; Masuda Y; Imaizumi H; Hashiguchi T; Maruyama I
J Leukoc Biol; 2009 Sep; 86(3):645-53. PubMed ID: 19581374
[TBL] [Abstract][Full Text] [Related]
35. Inducible and reversible suppression of Npm1 gene expression using stably integrated small interfering RNA vector in mouse embryonic stem cells.
Wang BB; Lu R; Wang WC; Jin Y
Biochem Biophys Res Commun; 2006 Sep; 347(4):1129-37. PubMed ID: 16870143
[TBL] [Abstract][Full Text] [Related]
36. Nucleophosmin is required for chromosome congression, proper mitotic spindle formation, and kinetochore-microtubule attachment in HeLa cells.
Amin MA; Matsunaga S; Uchiyama S; Fukui K
FEBS Lett; 2008 Nov; 582(27):3839-44. PubMed ID: 18951898
[TBL] [Abstract][Full Text] [Related]
37. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
Harada Y; Harada H
J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
[TBL] [Abstract][Full Text] [Related]
38. NPM1 ablation induces HSC aging and inflammation to develop myelodysplastic syndrome exacerbated by p53 loss.
Morganti C; Ito K; Yanase C; Verma A; Teruya-Feldstein J; Ito K
EMBO Rep; 2022 May; 23(5):e54262. PubMed ID: 35229971
[TBL] [Abstract][Full Text] [Related]
39. The potential role of nucleophosmin (NPM1) in the development of cancer.
Karimi Dermani F; Gholamzadeh Khoei S; Afshar S; Amini R
J Cell Physiol; 2021 Nov; 236(11):7832-7852. PubMed ID: 33959979
[TBL] [Abstract][Full Text] [Related]
40. Progression elevated gene-3 (PEG-3) induces pleiotropic effects on tumor progression: modulation of genomic stability and invasion.
Emdad L; Sarkar D; Su ZZ; Boukerche H; Bar-Eli M; Fisher PB
J Cell Physiol; 2005 Jan; 202(1):135-46. PubMed ID: 15389539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
